Showing results (201-210 of 243) with videos related to
Sort By:
Pageof 25
Neuro-Oncology|September 21, 2014
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastomaMarta Penas-Prado, Kenneth R Hess, Michael J Fisch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.Nature Genetics|October 11, 2016
The genomic landscape of schwannomaSameer Agnihotri, Shahrzad Jalali, Mark R Wilson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable MelanomaElizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.Acta Neuropathologica|April 9, 2025
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patientsOmkar Singh, Christopher Dampier, Zied Abdullaev, et al.Journal of the National Cancer Institute|December 16, 2015
TERT Promoter Mutations and Risk of Recurrence in MeningiomaFelix Sahm, Daniel Schrimpf, Adriana Olar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of originAlbert Lai, Samir Kharbanda, Whitney B Pope, et al.Oncoimmunology|November 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanomaMichael G White, Robert Szczepaniak Sloane, Russell G Witt, et al.Cancer Cell|September 3, 2013
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastomaKrishna P L Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, et al.The Journal of Experimental Medicine|September 30, 2024
An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axisIan W Folkert, William A Molina Arocho, Tsun Ki Jerrick To, et al.Pageof 25